Expansion, in vivo–ex vivo cycling, and genetic manipulation of primary human hepatocytes
Open Access
- 8 January 2020
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (3) , 1678-1688
Abstract
Primary human hepatocytes (PHHs) are an essential tool for modeling drug metabolism and liver disease. However, variable plating efficiencies, short lifespan in culture, and resistance to genetic manipulation have limited their use. Here, we show that the pyrrolizidine alkaloid retrorsine improves PHH repopulation of chimeric mice on average 10-fold and rescues the ability of even poorly plateable donor hepatocytes to provide cells for subsequent ex vivo cultures. These mouse-passaged (mp) PHH cultures overcome the marked donor-to-donor variability of cryopreserved PHH and remain functional for months as demonstrated by metabolic assays and infection with hepatitis B virus and Plasmodium falciparum . mpPHH can be efficiently genetically modified in culture, mobilized, and then recultured as spheroids or retransplanted to create highly humanized mice that carry a genetically altered hepatocyte graft. Together, these advances provide flexible tools for the study of human liver disease and evaluation of hepatocyte-targeted gene therapy approaches.Keywords
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI091707)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK085713)
- HHS | NIH | National Heart, Lung, and Blood Institute (R01HL131093)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (K08DK090576)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (F32DK107164)
- Bill and Melinda Gates Foundation (OPP1023607)
- Koch Institute Support Grant (P30-CA14051)
This publication has 34 references indexed in Scilit:
- Engineered Livers for Infectious DiseasesCellular and Molecular Gastroenterology and Hepatology, 2017
- Broadly neutralizing antibodies abrogate established hepatitis C virus infectionScience Translational Medicine, 2014
- The reconstituted ‘humanized liver’ in TK-NOG mice is mature and functionalBiochemical and Biophysical Research Communications, 2011
- Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatmentJournal of Clinical Investigation, 2010
- Repopulation of adult and neonatal mice with human hepatocytes: A chimeric animal modelProceedings of the National Academy of Sciences, 2007
- Idiosyncratic drug hepatotoxicityNature Reviews Drug Discovery, 2005
- Morphological and biochemical characterization of a human liver in a uPA‐SCID mouse chimera†‡Hepatology, 2005
- Long-Term, Near-Total Liver Replacement by Transplantation of Isolated Hepatocytes in Rats Treated with RetrorsineThe American Journal of Pathology, 1998
- Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice.Genes & Development, 1993
- The conversion of the pyrrolizidine alkaloid retrorsine to pyrrolic derivatives in vivo and in vitro and its acute toxicity to various animal speciesChemico-Biological Interactions, 1973